I am an Adjunct professor at the University of Twente, The Netherlands. Throughout my academic journey, I have been recognized for my scholarly achievements ranking highly in secondary school (2nd rank), bachelor (3rd University rank) and master (3rd University rank) education. In 2002, I received the prestigious CSIR-NET research fellowship in India (<1% success) to pursue my PhD research on Hepatitis B at AIIMS, India. My first PhD (2002-2007) was challenging and was incomplete due to supervisory issues, but I persisted and completed a second PhD (Sep. 2007 – Jan. 2012) at the University of Groningen funded by Ubbo Emmius fellowship focusing on liver fibrosis and cancer, resulting in numerous publications (7) and patents (2). I received the European Association for the Study of the Liver (EASL) Sheila Sherlock fellowship, and The Ruth and Richard Julin’s Swedish Foundation research grant (June 2011 – Sept. 2012; <10% success) for pursuing postdoctoral research on hepatitis C induced liver fibrosis at the Karolinska University hospital, Sweden. In 2012, I joined the University of Twente as a postdoctoral researcher with a vision to establish my own research line focusing on personalized understanding, diagnosis-prognosis, and treatment of liver diseases and cancer. To realize my ambition, in 2014, I secured the VENI grant, a prestigious early career personal grant from the Dutch Research Organization, NWO (11% success rate). In 2016, I transitioned to an Assistant Professor and acquired several individual: Gastrostart 2016, Incentive fund 2017, Take-off Phase I valorization grant 2017, Phospholipid research council 2020; and collaborative grants: NWO-NACTAR project 2018, Twente-Muenster Booster Program 2019, Twente University-Radboud UMC TURBO 2019 and Pioneers in Healthcare PIHC voucher 2019) and published numerous articles (20), supervised master (8) and PhD (2) students in 2016-2020. In 2020, I moved to the Department of Medical Cell BioPhysics (MCBP) and established my independent research lab. Focus of my lab lies in understanding metabolic liver diseases and how metabolic liver disease drive liver cancer and cancer metastasis. We aim to identify diagnostic and therapeutic targets using liquid biopsies for early diagnosis, prognosis and treatment. With this, our over-arching goal is to identify at-risk patients and to develop tailored treatment. My lab's mission is to bring scientific knowledge and innovations from bench to bedside to serve science and patients.
Expertise
Medicine and Dentistry
- Combination Therapy
- Macrophage
- Hepatic Stellate Cell
- Liver Fibrosis
- Liver
- Gamma Interferon
Pharmacology, Toxicology and Pharmaceutical Science
- Fibrosis
- Liver Injury
Organisations
Focus of my lab lies in metabolic liver diseases and metabolic liver disease driven liver cancer and cancer metastasis. We aim to understand underlying disease mechanisms, identify diagnostic and therapeutic targets using liquid biopsies for early diagnosis, prognosis and treatment. With this, our over-arching goal is to identify at-risk patients and to develop tailored treatment. My lab's mission is to bring scientific knowledge and innovations from bench to bedside to serve science and patients.
Publications
Jump to: 2025 | 2024 | 2023 | 2022
2025
2024
2023
2022
Research profiles
University Teaching Qualification:
- University teaching qualification successfully completed in 2017.
- English proficiency assessment (C1/C2) successfully completed in 2019
Educational activities:
- Coordinator and teacher, Advanced Anatomy and Physiology Course (designed a new course in 2023).
- Coordinator and teacher, Biochemistry master course (Course redesigned in 2023).
- Coordinator, BMT-M1 bachelor module (2021-2024).
- Coordinator and teacher, Controlled Drug and Gene Delivery master course (merged with Advanced Drug Delivery and Nanomedicine since 2022).
- Supervisor of Capita Selecta’s, ATLAS bachelor students and international master internships.
Affiliated study programs
Courses academic year 2025/2026
Courses in the current academic year are added at the moment they are finalised in the Osiris system. Therefore it is possible that the list is not yet complete for the whole academic year.
- 193640999 - Internship BME
- 201400266 - Capita Selecta BME TNW-BST
- 201400273 - Capita Selecta BME TNW-MCBP
- 201900212 - Additional Intern. & Job Orient. Project
- 201900214 - Internship & Job Orientation Pr. CSE/AP
- 202300229 - Internship BME/EE
- 202300330 - Multidisciplinary Project CSE
- 202400738 - Internship BME/ROB
Courses academic year 2024/2025
- 193640999 - Internship BME
- 193650999 - Masters Assignment
- 193799700 - CR Assignment (Studytrip)
- 201300054 - MSc final project SRA
- 201300055 - MSc final project RGA
- 201400266 - Capita Selecta BME TNW-BST
- 201400273 - Capita Selecta BME TNW-MCBP
- 201700174 - Internship & Job Orientation Project NT
- 201800413 - MSc final project SRA
- 201900212 - Additional Intern. & Job Orient. Project
- 201900214 - Internship & Job Orientation Pr. CSE/AP
- 201900316 - MSc Assignment AP/CSE Scientific Aspects
- 201900317 - MSc Assignment AP/CSE General Aspects
- 202300081 - Advanced Anatomy and Physiology
- 202300227 - Prep. MSc Assignment CSE/Parma 2.5 EC
- 202300228 - Prep. MSc Assignment CSE/Parma 5 EC
- 202300229 - Internship BME/EE
- 202300330 - Multidisciplinary Project CSE
- 202400318 - M12 BSc Assignment BMT
- 202400738 - Internship BME/ROB
Courses academic year 2023/2024
- 193640999 - Internship BME
- 193650999 - Masters Assignment
- 193740050 - Biochemistry
- 193799700 - CR Assignment (Studytrip)
- 201300054 - MSc final project SRA
- 201300055 - MSc final project RGA
- 201400266 - Capita Selecta BME TNW-BST
- 201400273 - Capita Selecta BME TNW-MCBP
- 201700174 - Internship & Job Orientation Project NT
- 201800413 - MSc final project SRA
- 201900212 - Additional Intern. & Job Orient. Project
- 201900214 - Internship & Job Orientation Pr. CSE/AP
- 201900316 - MSc Assignment AP/CSE Scientific Aspects
- 201900317 - MSc Assignment AP/CSE General Aspects
- 202000880 - M12 BSc Assignment BMT
- 202001528 - Master Thesis DD Parma
- 202300081 - Advanced Anatomy and Physiology
- 202300097 - M1 Mol. Constr. of the Human Body
- 202300227 - Prep. MSc Assignment CSE/Parma 2.5 EC
- 202300228 - Prep. MSc Assignment CSE/Parma 5 EC
- 202300229 - Internship BME/EE
- 202300330 - Multidisciplinary Project CSE
Ongoing Grants
- 2025-2030 NWO-OTP – Tissue Spatial Secretomics using Surface Plasmon Resonance imaging (TissueSPRi) (€1,022,428; Main PI)
- 2024-2025 KWF-PoC – MagNeedle for CTC isolation (€147,933; Main PI)
- 2024-2025 KWF-PoC – Utilization of FETCH Technology (€155,157; Main PI)
- 2025-2026 NWO-Take-Off Phase I – FETCH Technology (39,987; Main PI)
- 2024-2028 KWF-PPS - Engineering Therapeutic Monoclonal Antibodies for the Treatment of Liver Cancer (€1,369,070; Main PI)
- 2023-2027 KWF-PPS - Unlocking the potential of autotaxin inhibition for the treatment of liver cancer
- project grant (€829,400; Main PI)
- 2020-2025 KWF-NWO (PICTURES) project grant (€919,218; Co-PI)
Grants/fellowships (completed)
- 2023-2024 Twente University RadBoudumc Opportunities (TURBO) program grant (€80,000): Main PI
- 2020-2024 TKI-HTSM (ATX-NASH) project grant (€306,000; Main PI)
- 2019-2020 Pioneers in Healthcare (PIHC) project grant (€60,000): Main PI
- 2019-2020 Twente University RadBoudumc Opportunities (TURBO) program grant (€80,000): Main PI
- 2019-2022 Phospholipid research council grant (€120,000): Main PI
- 2019-2020 BOOSTER project (UT-WWU): Cross-border Collaboration UT Twente-WWU Muenster On Imaging for Diagnosis and Therapy (€35,000): Main PI
- 2018-2021 NWO-TTW NACTAR collaborative grant (€800,000): Co-PI
- 2017-2019 Take-off Phase-I valorization grant (€40,000) from TTW, NWO: Main PI
- 2017-2018 UT incentive Fund (€4000) from University of Twente, The Netherlands: Main PI
- 2016-2017 Gastrostart Grant (€7500) from Netherlands Society of Gastroenterology (NVGE): Main PI
- 2014-2017 VENI Innovation grant (€250,000) from ZonMw, NWO: Main PI
- 2012-2013 The Ruth and Richard Julin’s Foundation Swedish research grant (€ 5000): Main PI
- 2011-2012 Sheila Sherlock Research Fellowship (€50,000), EASL Switzerland: Main PI
- Vijf vrouwelijke UT-toppers in Viva-lijst van rolmodellen: ‘Ik vind het een eer’ | Foto | destentor.nl
- Vijf vrouwelijke UT-toppers in Viva-lijst van rolmodellen - 1Twente
- Vijf vrouwelijke UT-toppers in Viva-lijst van rolmodellen: ‘Ik vind het een eer’ | Enschede | tubantia.nl
- Vijf UT-onderzoekers in VIVA400 - U-Today
- News in Tubantia Jan 2020, Deze Twentse pioniers in de gezondheidszorg staan op de rand van een doorbraak https://lnkd.in/ghAcqK9
- Rising star, U-Today Science & Technology Magazine # 8. https://issuu.com/utnieuws/docs/utodaysciencemag8
- Interview highlighted in Lever May 2019
- https://www.hepatologie.org/sites/www.hepatologie.org/files/Site%20Lever%202%202019.pdf
- Hind Rattan award 2019: https://www.utwente.nl/en/news/!/2019/2/178694/dr.-ruchi-bansal-received-hind-rattan-award
- AASLD Young investigator award 2018: https://www.utwente.nl/en/news/!/2018/12/448182/dr.-ruchi-bansal-awarded-with-prestigious-young-investigator-award
- Love your liver 2018: https://www.utoday.nl/science/65283/love-your-liver
- UEG National scholar award 2017: https://www.utwente.nl/en/news/!/2017/11/281902/ruchi-bansal-wins-uegs-national-scholar-award
- Research highlighted in Lever 2015 (http://www.hepatologie.org/files/LEVER%203_15.pdf).
- VENI NWO Grant 2014: https://www.utwente.nl/en/news/!/2014/7/208942/veni-grant-for-ruchi-bansal-for-the-development-of-targeted-nanotherapeutics-against-liver-fibrosis; https://issuu.com/utwente/docs/universiteit_twente_jaarverslag_201/53; https://www.utoday.nl/news/60335/Drie_UTonderzoekers_scoren_een_Venibeurs
Address

University of Twente
Carré (building no. 15)
Hallenweg 23
7522 NH Enschede
Netherlands
University of Twente
Carré
P.O. Box 217
7500 AE Enschede
Netherlands